Drug Profile
Beclometasone controlled-release - Chiesi
Alternative Names: Beclomethasone controlled-release - Chiesi; Beclomethasone dipropionate controlled-release - Chiesi; CHF-1514; Clipper; EUR-1073Latest Information Update: 19 Dec 2021
Price :
$50
*
At a glance
- Originator Chiesi Farmaceutici
- Developer Chiesi Farmaceutici; Eurand
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Chlorinated steroids; Corticosteroids; Pregnadienetriols; Small molecules; Vascular disorder therapies
- Mechanism of Action Immunosuppressants; Steroid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Ulcerative colitis
- Discontinued Inflammatory bowel diseases
Most Recent Events
- 16 May 2017 Chiesi initiates enrolment in the BeCalCU phase III trial for Ulcerative colitis in Spain (EudraCT2017-000330-61)
- 03 Feb 2014 Aptalis has been acquired by Forest Laboratories
- 11 Feb 2011 Eurand has been acquired and merged into Axcan Pharma